title: [Helicobacter pylori infection enhances atherosclerosis in high-cholesterol diet fed C57BL/6 mice].
abstract: OBJECTIVE
  To evaluate the impacts of Helicobacter pylori (H. pylori) infection on atherosclerosis and plasma lipid levels in high-cholesterol diet fed C57BL/6 mice.
  
  
  METHODS
  Female C57BL/6 mice were randomly divided into 4 groups (n = 12 each): fed with normal chow diet (A), infected with H. pylori (B), fed with high-cholesterol diet (C) and infected with H. pylori and fed with high-cholesterol diet (D). After 52 weeks, plasma levels of lipids were measured and aortic atherosclerosis was observed. The ureA, ureC, cagA and vacA DNA were also detected by PCR in the aortic arteries.
  
  
  RESULTS
  (1) Prevalence of atherosclerosis was similar between group C and D (91.6% vs. 100%, P > 0.05) while there was no atherosclerosis in group A and B. H. pylori infected mice showed more obvious inflammation in gastric mucosa than mice without H. pylori infection. (2) The plasma levels of triglyceride, total cholesterol and LDL were higher and HDL was lower in group B, C and D than those in group A and in group D than in group C (all P < 0.05). (3) Roberts & Thompson scores and number of foam cells in plaques were significantly higher in group D compared with those in group C (all P < 0.05). (4) ureC DNA was detected in 5 out of 12 aortic arteries of mice in group D but not in group A, B and C.
  
  
  CONCLUSIONS
  Our results suggested that H. pylori infection might enhance the atherosclerotic lesion formation in this mouse model.
authors.affiliation: Emergency Department of Second Hospital of Jilin University, Changchun 130041, China.
authors.forename: Xing-hai
authors.initials: XH
authors.lastname: Chen
authors.forename: Jiang-bin
authors.initials: JB
authors.lastname: Wang
authors.forename: Yu-shan
authors.initials: YS
authors.lastname: Wang
authors.forename: Zhong-min
authors.initials: ZM
authors.lastname: Liu
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000382:microbiology* / Q000473:pathology*; D001426:Bacterial Proteins / Q000235:genetics; D001427:Bacterial Toxins / Q000235:genetics; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000009:adverse effects*; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D016481:Helicobacter Infections / Q000473:pathology*; D016480:Helicobacter pylori / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D014280:Triglycerides / Q000097:blood; D014510:Urease / Q000235:genetics
chemical_list: D001426:Bacterial Proteins; D001427:Bacterial Toxins; D002791:Cholesterol, Dietary; D004269:DNA, Bacterial; D014280:Triglycerides; C074689:VacA protein, Helicobacter pylori; D002784:Cholesterol; D014510:Urease